Home pageCRL • NYSE
add
Charles River Laboratories International, Inc.
165,84 $
After Hours:(0,00%)0,00
165,84 $
Data e ora chiusura: 27 gen, 17:11:34 GMT-5 · USD · NYSE · Disclaimer
Chiusura precedente
164,97 $
Intervallo giornaliero
164,92 $ - 168,55 $
Intervallo annuale
160,85 $ - 275,00 $
Cap di mercato
8,48 Mld USD
Volume medio
783.694,00
Rapporto P/E
20,70
Dividendo/Prezzo
-
Borsa valori principale
NYSE
Notizie del mercato finanziario
Dati finanziari
Conto economico
Entrate
Utile netto
| (USD) | set 2024info | Variazione Y/Y |
|---|---|---|
Entrate | 1,01 Mld | -1,64% |
Spese di gestione | 219,42 Mln | 5,38% |
Utile netto | 69,66 Mln | -20,29% |
Margine di profitto netto | 6,90 | -18,92% |
Utili per azione | 2,59 | -4,78% |
EBITDA | 236,55 Mln | -4,13% |
Aliquota fiscale effettiva | 22,96% | — |
Stato patrimoniale
Totale attivo
Totale passivo
| (USD) | set 2024info | Variazione Y/Y |
|---|---|---|
Investimenti cash/breve termine | 210,17 Mln | 33,72% |
Totale attivo | 8,00 Mld | 5,22% |
Totale passivo | 4,18 Mld | -1,88% |
Patrimonio netto totale | 3,83 Mld | — |
Azioni in circolazione | 51,14 Mln | — |
Prezzo/valore contabile | 2,23 | — |
Redditività dell'attivo | 4,65% | — |
Rendimento sul capitale | 5,62% | — |
Flusso di cassa
Flusso di cassa netto
| (USD) | set 2024info | Variazione Y/Y |
|---|---|---|
Utile netto | 69,66 Mln | -20,29% |
Liquidità di esercizio | 251,79 Mln | 22,56% |
Contanti da investimenti | -21,32 Mln | 73,20% |
Contanti da finanziamenti | -207,54 Mln | -27,43% |
Flusso di cassa netto | 30,64 Mln | 170,98% |
Flusso di cassa libero | 223,49 Mln | 120,91% |
Informazioni
Charles River Laboratories International, Inc. is an American pharmaceutical company specializing in a variety of preclinical and clinical laboratory, gene therapy and cell therapy services for the pharmaceutical, medical device and biotechnology industries. It also supplies assorted biomedical products, outsourcing services, and animals for research and development in the pharmaceutical industry and offers support in the fields of basic research, drug discovery, safety and efficacy, clinical support, and manufacturing.
Its customers include leading pharmaceutical, biotechnology, agrochemical, government, and academic organization around the globe. The company has over 150 facilities, operates in 21 countries, and employs over 21,000 people worldwide.
Charles River Laboratories is often criticized by animal rights activists who condemn the company's usage of dogs and non-human primates for pharmaceutical purposes. The company is also a major harvester of horseshoe crab blood. Wikipedia
Fondazione
1947
Sito web
Dipendenti
21.100
